243 related articles for article (PubMed ID: 9921924)
21. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
Kucukates E; Erturan Z; Susever S; Yegenoglu Y
APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
[TBL] [Abstract][Full Text] [Related]
22. Epidemiological trends in nosocomial candidemia in intensive care.
Bassetti M; Righi E; Costa A; Fasce R; Molinari MP; Rosso R; Pallavicini FB; Viscoli C
BMC Infect Dis; 2006 Feb; 6():21. PubMed ID: 16472387
[TBL] [Abstract][Full Text] [Related]
23. [A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)].
Rodríguez-Tudela JL; Cuenca-Estrella M
Rev Clin Esp; 1999 Jun; 199(6):356-61. PubMed ID: 10432809
[TBL] [Abstract][Full Text] [Related]
24. Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria.
Presterl E; Daxböck F; Graninger W; Willinger B
Clin Microbiol Infect; 2007 Nov; 13(11):1072-6. PubMed ID: 17725647
[TBL] [Abstract][Full Text] [Related]
25. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
Hope W; Morton A; Eisen DP
J Hosp Infect; 2002 Jan; 50(1):56-65. PubMed ID: 11825053
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
27. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
[TBL] [Abstract][Full Text] [Related]
29. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
30. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
[TBL] [Abstract][Full Text] [Related]
31. Candidemia in neonatal intensive care unit.
Gupta N; Mittal N; Sood P; Kumar S; Kaur R; Mathur MD
Indian J Pathol Microbiol; 2001 Jan; 44(1):45-8. PubMed ID: 12561995
[TBL] [Abstract][Full Text] [Related]
32. [Retrospective evaluation of the cases with Candida famata fungemia in a burn unit].
Turunç T; Demiroğlu YZ; Alişkan H; Colakoğlu S; Arslan H
Mikrobiyol Bul; 2009 Jan; 43(1):71-6. PubMed ID: 19334382
[TBL] [Abstract][Full Text] [Related]
33. Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
Gottfredsson M; Vredenburgh JJ; Xu J; Schell WA; Perfect JR
Cancer; 2003 Jul; 98(1):24-30. PubMed ID: 12833451
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of candidemia in a Turkish tertiary care hospital.
Bakir M; Cerikcioglu N; Barton R; Yagci A
APMIS; 2006 Sep; 114(9):601-10. PubMed ID: 16948812
[TBL] [Abstract][Full Text] [Related]
35. Candida krusei fungemia. An escalating serious infection in immunocompromised patients.
Abbas J; Bodey GP; Hanna HA; Mardani M; Girgawy E; Abi-Said D; Whimbey E; Hachem R; Raad I
Arch Intern Med; 2000 Sep; 160(17):2659-64. PubMed ID: 10999981
[TBL] [Abstract][Full Text] [Related]
36. Neonatal candidaemia in Kuwait: a 12-year study of risk factors, species spectrum and antifungal susceptibility.
Al-Sweih N; Khan Z; Khan S; Devarajan LV
Mycoses; 2009 Nov; 52(6):518-23. PubMed ID: 18983425
[TBL] [Abstract][Full Text] [Related]
37. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.
Al-Tawfiq JA
Int J Infect Dis; 2007 May; 11(3):239-44. PubMed ID: 16859945
[TBL] [Abstract][Full Text] [Related]
38. [Nosocomial fungemia caused by Candida parapsilosis].
Herrero JA; Lumbreras C; Sanz F; Lizasoain M; Aguado JM; Pastor C; Noriega AR
Enferm Infecc Microbiol Clin; 1992 Nov; 10(9):520-4. PubMed ID: 1489791
[TBL] [Abstract][Full Text] [Related]
39. Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan.
Chen TC; Chen YH; Tsai JJ; Peng CF; Lu PL; Chang K; Hsieh HC; Chen TP
J Microbiol Immunol Infect; 2005 Jun; 38(3):200-10. PubMed ID: 15986071
[TBL] [Abstract][Full Text] [Related]
40. Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
Myoken Y; Kyo T; Kohara T; Fujihara M; Sugata T; Mikami Y
Clin Infect Dis; 2003 Jun; 36(11):1496-7. PubMed ID: 12766847
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]